Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zoltán Kaló

Showing results (1-10 of 146) with videos related to

Pageof 15
Sort By:
Expert Review of Pharmacoeconomics & Outcomes Research|March 1, 2011
Health technology assessment: a European collaborationZoltán Kaló, Zoltán Vokó
British Journal of Pharmacology|February 6, 2010
Principles of pharmacoeconomics and their impact on strategic imperatives of pharmaceutical research and developmentJózsef Bodrogi, Zoltán Kaló
Acta Pharmaceutica Hungarica|May 11, 2012
[Risk sharing methods in middle income countries]András Inotai, Zoltán Kaló
Expert Review of Pharmacoeconomics & Outcomes Research|December 8, 2019
How to solve financing gap to ensure patient access to patented pharmaceuticals in CEE countries? - the good, the bad, and the ugly waysAndrás Inotai, Zoltán Kaló
Acta Pharmaceutica Hungarica|July 29, 2009
[Decision analytic modeling and their impact on health care decision making]András Inotai, Zoltán Kaló, Agnes Mészáros
Antiviral Therapy|January 18, 2019
Cost-effectiveness of second-generation direct-acting antiviral agents in chronic HCV infection: a systematic literature reviewLászló Szilberhorn, Zoltán Kaló, Tamás Ágh
Acta Pharmaceutica Hungarica|March 17, 2011
[Assessment of the pharmaceutical expenditure in Hungary]András Inotai, Gergo Merész, Zoltán Kaló
International Journal of Technology Assessment in Health Care|April 25, 2017
OVERVIEW ON THE CURRENT IMPLEMENTATION OF HEALTH TECHNOLOGY ASSESSMENT IN THE HEALTHCARE SYSTEM IN HUNGARYBertalan Németh, Marcell Csanádi, Zoltán Kaló
BMC Public Health|November 1, 2012
Cost-effectiveness of adding vaccination with the AS04-adjuvanted human papillomavirus 16/18 vaccine to cervical cancer screening in HungaryZoltán Vokó, László Nagyjánosi, Zoltán Kaló
Expert Review of Pharmacoeconomics & Outcomes Research|November 14, 2013
Differential pricing of new pharmaceuticals in lower income European countriesZoltán Kaló, Lieven Annemans, Louis P Garrison
Pageof 15

Showing results (1-10 of 146) with videos related to

Sort By:
Pageof 15
Expert Review of Pharmacoeconomics & Outcomes Research|March 1, 2011
Health technology assessment: a European collaborationZoltán Kaló, Zoltán Vokó
British Journal of Pharmacology|February 6, 2010
Principles of pharmacoeconomics and their impact on strategic imperatives of pharmaceutical research and developmentJózsef Bodrogi, Zoltán Kaló
Acta Pharmaceutica Hungarica|May 11, 2012
[Risk sharing methods in middle income countries]András Inotai, Zoltán Kaló
Expert Review of Pharmacoeconomics & Outcomes Research|December 8, 2019
How to solve financing gap to ensure patient access to patented pharmaceuticals in CEE countries? - the good, the bad, and the ugly waysAndrás Inotai, Zoltán Kaló
Acta Pharmaceutica Hungarica|July 29, 2009
[Decision analytic modeling and their impact on health care decision making]András Inotai, Zoltán Kaló, Agnes Mészáros
Antiviral Therapy|January 18, 2019
Cost-effectiveness of second-generation direct-acting antiviral agents in chronic HCV infection: a systematic literature reviewLászló Szilberhorn, Zoltán Kaló, Tamás Ágh
Acta Pharmaceutica Hungarica|March 17, 2011
[Assessment of the pharmaceutical expenditure in Hungary]András Inotai, Gergo Merész, Zoltán Kaló
International Journal of Technology Assessment in Health Care|April 25, 2017
OVERVIEW ON THE CURRENT IMPLEMENTATION OF HEALTH TECHNOLOGY ASSESSMENT IN THE HEALTHCARE SYSTEM IN HUNGARYBertalan Németh, Marcell Csanádi, Zoltán Kaló
BMC Public Health|November 1, 2012
Cost-effectiveness of adding vaccination with the AS04-adjuvanted human papillomavirus 16/18 vaccine to cervical cancer screening in HungaryZoltán Vokó, László Nagyjánosi, Zoltán Kaló
Expert Review of Pharmacoeconomics & Outcomes Research|November 14, 2013
Differential pricing of new pharmaceuticals in lower income European countriesZoltán Kaló, Lieven Annemans, Louis P Garrison
Pageof 15